Evaluation of Syringin's Neuroprotective Effect in a Model of Neonatal Hypoxic-ischemic Brain Injury

Overview

Journal Turk J Med Sci

Specialty General Medicine

Date 2024 May 30

PMID 38813032

Authors

Ezgi Yangin Ergon

Asli Celik

Gulden Diniz

Ruya Colak

Senem Alkan Ozdemir

Sebnem Calkavur

Osman Yilmaz

Affiliations

Soon will be listed here.

Abstract

Background/aim: A significant cause of mortality and morbidity in the neonatal era is hypoxic-ischemic encephalopathy (HIE). This study examined the histopathological analysis and neuroprotective impact of syringin (SYR) in an experimental HIE rat model.

Material And Methods: On the 7th postnatal day, 24 Wistar albino rats were evaluated in 3 groups using the HIE model under gas anesthesia. In the experiment, Group A received 10 mg/kg SYR plus dimethyl sulfoxide (DMSO), Group B received DMSO only, and Group C served as a sham group. Immunohistochemical techniques were used to assess apoptotic cell measurement and proinflammatory cytokines (TNF-α and IL-1β primary antibodies).

Results: Rats suffering from hypoxic-ischemic brain damage had their apoptosis assessed. The SYR and sham groups had statistically fewer cells undergoing apoptosis (p < 0.001). There was no difference between the groups in terms of IL-1β and TNF-α during immunohistochemical staining. Neuronal degeneration was significantly lower in the histological evaluation of the hippocampus in the SYR group (p = 0.01). A statistically significant difference (p = 0.01) was observed between the SYR and the control groups regarding pericellular and perivascular edema.

Conclusion: SYR reduced apoptosis, perivascular and pericellular edema, and neuronal degeneration in rat cerebral tissue. These results raise the possibility that SYR may have a neuroprotective effect on the harm brought on by HIE. This is the first investigation of SYR's function within the HIE paradigm.

References

Yi J, Park S, Kapadia R, Vemuganti R . Role of transcription factors in mediating post-ischemic cerebral inflammation and brain damage. Neurochem Int. 2007; 50(7-8):1014-27. PMC: 2040388. DOI: 10.1016/j.neuint.2007.04.019. View

Wu Q, Chen W, Sinha B, Tu Y, Manning S, Thomas N . Neuroprotective agents for neonatal hypoxic-ischemic brain injury. Drug Discov Today. 2015; 20(11):1372-81. DOI: 10.1016/j.drudis.2015.09.001. View

Kim N, Pae H, Ko Y, Yoo J, Choi B, Jun C . In vitro inducible nitric oxide synthesis inhibitory active constituents from Fraxinus rhynchophylla. Planta Med. 1999; 65(7):656-8. DOI: 10.1055/s-2006-960840. View

Colak R, Celik A, Diniz G, Alkan Ozdemir S, Yilmaz O, Calkavur S . Evaluation of the Neuroprotective Effect of Pycnogenol in a Hypoxic-Ischemic Brain Injury Model in Newborn Rats. Am J Perinatol. 2021; 40(6):612-618. DOI: 10.1055/s-0041-1730349. View

Arteaga O, Alvarez A, Revuelta M, Santaolalla F, Urtasun A, Hilario E . Role of Antioxidants in Neonatal Hypoxic-Ischemic Brain Injury: New Therapeutic Approaches. Int J Mol Sci. 2017; 18(2). PMC: 5343801. DOI: 10.3390/ijms18020265. View

Liu Y, Zhu X, Tong X, Tan Z . Syringin protects against cerebral ischemia/reperfusion injury via inhibiting neuroinflammation and TLR4 signaling. Perfusion. 2021; 37(6):562-569. DOI: 10.1177/02676591211007025. View

Wu G, McBride D, Zhang J . Axl activation attenuates neuroinflammation by inhibiting the TLR/TRAF/NF-κB pathway after MCAO in rats. Neurobiol Dis. 2017; 110:59-67. PMC: 5748011. DOI: 10.1016/j.nbd.2017.11.009. View

Yang E, Kim S, Ku H, Lee D, Lee J, Kim Y . Syringin from stem bark of Fraxinus rhynchophylla protects Abeta(25-35)-induced toxicity in neuronal cells. Arch Pharm Res. 2010; 33(4):531-8. DOI: 10.1007/s12272-010-0406-z. View

Higgins R, Raju T, Edwards A, Azzopardi D, Bose C, Clark R . Hypothermia and other treatment options for neonatal encephalopathy: an executive summary of the Eunice Kennedy Shriver NICHD workshop. J Pediatr. 2011; 159(5):851-858.e1. PMC: 3263823. DOI: 10.1016/j.jpeds.2011.08.004. View

10.

Kurinczuk J, White-Koning M, Badawi N . Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. Early Hum Dev. 2010; 86(6):329-38. DOI: 10.1016/j.earlhumdev.2010.05.010. View

11.

Davydov M, Krikorian A . Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. (Araliaceae) as an adaptogen: a closer look. J Ethnopharmacol. 2000; 72(3):345-93. DOI: 10.1016/s0378-8741(00)00181-1. View

12.

Ezenwa B, Olorunfemi G, Fajolu I, Adeniyi T, Oleolo-Ayodeji K, Kene-Udemezue B . Trends and predictors of in-hospital mortality among babies with hypoxic ischaemic encephalopathy at a tertiary hospital in Nigeria: A retrospective cohort study. PLoS One. 2021; 16(4):e0250633. PMC: 8075215. DOI: 10.1371/journal.pone.0250633. View

13.

Kumral A, Ozer E, Yilmaz O, Akhisaroglu M, Gokmen N, Duman N . Neuroprotective effect of erythropoietin on hypoxic-ischemic brain injury in neonatal rats. Biol Neonate. 2003; 83(3):224-8. DOI: 10.1159/000068926. View

14.

Tagin M, Woolcott C, Vincer M, Whyte R, Stinson D . Hypothermia for neonatal hypoxic ischemic encephalopathy: an updated systematic review and meta-analysis. Arch Pediatr Adolesc Med. 2012; 166(6):558-66. DOI: 10.1001/archpediatrics.2011.1772. View

15.

Cho J, Nam K, Kim A, Park J, Yoo E, Baik K . In-vitro and in-vivo immunomodulatory effects of syringin. J Pharm Pharmacol. 2001; 53(9):1287-94. DOI: 10.1211/0022357011776577. View

16.

Alkan Ozdemir S, Ozdemir N, Aksan O, Kinali B, Bilici Guler G, Erbil G . Effect of humic acid on oxidative stress and neuroprotection in hypoxic-ischemic brain injury: part 1. J Matern Fetal Neonatal Med. 2022; 35(23):4580-4589. DOI: 10.1080/14767058.2020.1856809. View

17.

Choi J, Shin K, Park H, Jung H, Kim H, Lee Y . Anti-inflammatory and antinociceptive effects of sinapyl alcohol and its glucoside syringin. Planta Med. 2004; 70(11):1027-32. DOI: 10.1055/s-2004-832642. View

18.

Nair J, Kumar V . Current and Emerging Therapies in the Management of Hypoxic Ischemic Encephalopathy in Neonates. Children (Basel). 2018; 5(7). PMC: 6069156. DOI: 10.3390/children5070099. View

19.

Dixon B, Reis C, Ho W, Tang J, Zhang J . Neuroprotective Strategies after Neonatal Hypoxic Ischemic Encephalopathy. Int J Mol Sci. 2015; 16(9):22368-401. PMC: 4613313. DOI: 10.3390/ijms160922368. View

20.

Shih R, Wang C, Yang C . NF-kappaB Signaling Pathways in Neurological Inflammation: A Mini Review. Front Mol Neurosci. 2016; 8:77. PMC: 4683208. DOI: 10.3389/fnmol.2015.00077. View